RxDoctor Payments Data

Emily Wagler, DPM

Foot & Ankle Surgery · Federal Way, WANPI 1356899363

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Stryker at 38.0% of the total. Reporting peaked in 2022 at $6,668 and has fallen 91.1% since, to $594 in 2025.

$15,983in general payments, 2019–2025

Across 127 payments — averaging $125.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Arthrex$3K
  • Steelhead Surgical Inc$1K
  • Paragon 28, Inc.$1K
  • Orthofix Medical, Inc.$985
  • Zimmer Biomet$853
  • plus $3K from 11 others

What the payments were for

  • Speaking & faculty fees$1251%
  • Travel & lodging$6,56541%
  • Food & beverage$5,69436%
  • Education$3,60023%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,983 in reported general payments places this provider in the 85th percentile of 203 foot & ankle surgery providers in Washington.

See all foot & ankle surgery providers in Washington

Medicare billing

Part B allowed, 2024
$57,242
Medicare patients
248
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl24$109
Ondansetron Hcl13$84

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Federal Way

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →